CochLear Price to Book Ratio 2023-2023 | CHEOY
Historical price to book ratio values for CochLear (CHEOY) over the last 10 years. The current price to book ratio for CochLear as of June 27, 2024 is 12.17.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| CochLear Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 0.00 | nan | ||
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $14.127B | $1.317B |
| Cochlear Limited provides implantable hearing solutions principally in the Americas, Europe, the Middle East, Africa and the Asia Pacific. The company offers cochlear implants, including Nucleus 7 and Kanso sound processors; Carina middle-ear implants and accessories and Baha bone conduction implants. Cochlear Limited is based in Sydney, Australia. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $124.186B | 15.58 |
| Cencora (COR) | United States | $47.326B | 18.45 |
| ICON (ICLR) | Ireland | $25.819B | 24.38 |
| DiDi Global (DIDIY) | China | $21.143B | 0.00 |
| Avantor (AVTR) | United States | $14.910B | 21.95 |
| Natera (NTRA) | United States | $13.679B | 0.00 |
| Revvity (RVTY) | United States | $12.872B | 22.58 |
| Medpace Holdings (MEDP) | United States | $12.559B | 41.32 |
| Viatris (VTRS) | United States | $12.419B | 3.71 |
| Charles River Laboratories (CRL) | United States | $10.648B | 20.39 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $10.087B | 0.00 |
| Solventum (SOLV) | United States | $8.765B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.297B | 0.00 |
| HealthEquity (HQY) | United States | $7.205B | 46.26 |
| Organon (OGN) | United States | $5.305B | 5.03 |
| Bausch + Lomb (BLCO) | Canada | $5.197B | 20.80 |
| Doximity (DOCS) | United States | $5.131B | 35.94 |
| PACS (PACS) | United States | $4.464B | 0.00 |
| Life Times (LTH) | United States | $3.744B | 39.23 |
| Sotera Health (SHC) | United States | $3.349B | 16.43 |
| Surgery Partners (SGRY) | United States | $2.993B | 27.38 |
| GoodRx Holdings (GDRX) | United States | $2.949B | 112.29 |
| Agilon Health (AGL) | United States | $2.694B | 0.00 |
| Progyny (PGNY) | United States | $2.622B | 45.15 |
| AMN Healthcare Services Inc (AMN) | United States | $2.034B | 8.06 |
| NovoCure (NVCR) | Jersey | $1.954B | 0.00 |
| Premier (PINC) | United States | $1.939B | 8.30 |
| BrightSpring Health Services (BTSG) | United States | $1.849B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.721B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.566B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $1.451B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.199B | 0.00 | |
| CareDx (CDNA) | United States | $0.730B | 0.00 |
| Embecta (EMBC) | United States | $0.708B | 4.81 |
| GeneDx Holdings (WGS) | United States | $0.684B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.651B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.648B | 6.88 |
| Auna S.A (AUNA) | Luxembourg | $0.594B | 0.00 |
| Sharecare (SHCR) | United States | $0.497B | 0.00 |
| Enhabit (EHAB) | United States | $0.426B | 42.45 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.397B | 0.00 |
| ModivCare (MODV) | United States | $0.356B | 6.66 |
| QDM (QDMI) | Hong Kong, SAR China | $0.353B | 9.24 |
| Sonida Senior Living (SNDA) | United States | $0.342B | 0.00 |
| DocGo (DCGO) | United States | $0.312B | 17.06 |
| LifeMD (LFMD) | United States | $0.288B | 0.00 |
| MultiPlan (MPLN) | United States | $0.268B | 0.00 |
| Beauty Health (SKIN) | United States | $0.226B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.202B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.189B | 0.00 |
| Biodesix (BDSX) | United States | $0.172B | 0.00 |
| So-Young (SY) | China | $0.107B | 51.50 |
| Pono Capital Two (PTWO) | United States | $0.069B | 0.00 |
| NeueHealth (NEUE) | United States | $0.043B | 5.81 |
| Co-Diagnostics (CODX) | United States | $0.042B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.034B | 0.00 |
| Oncology Institute (TOI) | United States | $0.032B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.027B | 0.00 |
| Nutex Health (NUTX) | United States | $0.027B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.023B | 0.00 |
| OncoCyte (OCX) | United States | $0.022B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.019B | 0.00 |
| KindlyMD (KDLY) | $0.018B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.017B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.015B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| ISpecimen (ISPC) | United States | $0.005B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.004B | 0.00 |
| OpGen (OPGN) | United States | $0.003B | 0.00 |
| DermTech (DMTK) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.003B | 0.00 |
| Assure Holdings (IONM) | United States | $0.002B | 0.00 |